TPG Biotech Overview
Asset Management
Latest News
growth-positive
TPG tops up funds to $580M for investments across the life sciences spectrum
Asset manager TPG has increased its Life Science Innovations fund to a total of $580 million. The fund is used to support emerging life science companies, with a focus on those working in various medical fields and on different drug modalities and technology platforms. TPG will use this round of fundraising to seek companies across the spectrum, from preclinical to commercial to medical devices and pharma services. The $580 million in capital includes commitments from TPG’s The Rise Fund, which was used to contribute to Sionna Therapeutics’ $182 million series C in March.
Investment
Team Members
0
Web & Social Links
Locations
Texas, USA
Photos & Videos
No files yet
TPG Biotech Business
Business models
—
Product stage
—
Employees
—
Sector
—Target Customer
—Core Technology
—TPG Biotech Financials
—
Total funding
—
Capital raised
—
Last funding
—
Funding stage
—
Total rounds
—
Investors
TPG Biotech Lifecycle
TPG Biotech News
1 article
growth-positive
TPG tops up funds to $580M for investments across the life sciences spectrum
Asset manager TPG has increased its Life Science Innovations fund to a total of $580 million. The fund is used to support emerging life science companies, with a focus on those working in various medical fields and on different drug modalities and technology platforms. TPG will use this round of fundraising to seek companies across the spectrum, from preclinical to commercial to medical devices and pharma services. The $580 million in capital includes commitments from TPG’s The Rise Fund, which was used to contribute to Sionna Therapeutics’ $182 million series C in March.
Investment
TPG Biotech Team
No team members listed.
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
TPG Biotech Internal
Recent Updates
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-08-07 08:29:09.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-08-07 08:39:58.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-08-07 08:29:10.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-08-07 08:29:09.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-08-07 08:29:10.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-08-07 08:39:58.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-08-07 08:39:43.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-08-07 08:39:43.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-08-07 08:29:09.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-08-07 08:39:58.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-08-07 08:29:09.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-08-07 08:39:43.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-08-07 08:39:43.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-08-07 08:39:43.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2024-08-07 08:39:43.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-08-07 08:39:43.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2024-08-07 08:29:10.000000
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 25/100 |
| Missing | product stage, sector, number of employees, tags, invite member, business model, tag line, description, homepage, video or image, funding rounds, markets, external profiles, not claimed |
| Creator | RPA |
| Creator email | sncentraltest@gmail.com |
| Last update | 2022-06-14T00:00:00.000Z |
| Created | 2019-05-11T00:00:00.000Z |
| Status detail | Active |